NCT04036032View on ClinicalTrials.gov

Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 19, 2015

Primary Completion Date

August 27, 2025

Study Completion Date

August 27, 2025

Conditions

CancerCardiotoxicity

Interventions

OTHER

Exercise program

Encourage to work out 4 to 5 times a week for 3 months. Patient chooses what exercise they would like to do. At YMCA visit for fitness assessments they provide exercise support

Trial Locations (2)

43205

Nationwide Children's Hospital, Columbus

06106

CT Children's Medical Center, Hartford

All Listed Sponsors

collaborator

Nationwide Children's Hospital

OTHER

lead

Connecticut Children's Medical Center

OTHER

NCT04036032 - Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy | Biotech Hunter | Biotech Hunter